Arteris, Inc. (NASDAQ:AIP - Get Free Report) CFO Nicholas B. Hawkins sold 14,387 shares of the firm's stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $11.15, for a total transaction of $160,415.05. Following the sale, the chief financial officer now directly owns 169,868 shares in the company, valued at $1,894,028.20. This represents a 7.81 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Arteris Stock Performance
Shares of NASDAQ:AIP traded up $0.03 on Monday, reaching $12.28. 495,407 shares of the company's stock were exchanged, compared to its average volume of 869,555. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 0.30. Arteris, Inc. has a fifty-two week low of $4.83 and a fifty-two week high of $12.64. The business's 50-day moving average is $9.00 and its two-hundred day moving average is $8.08. The firm has a market capitalization of $493.37 million, a price-to-earnings ratio of -12.79 and a beta of 1.17.
Hedge Funds Weigh In On Arteris
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. State Street Corp boosted its stake in Arteris by 18.5% during the 3rd quarter. State Street Corp now owns 410,578 shares of the company's stock valued at $3,170,000 after purchasing an additional 64,081 shares in the last quarter. Bank of New York Mellon Corp acquired a new stake in shares of Arteris during the second quarter valued at approximately $580,000. Dynamic Technology Lab Private Ltd acquired a new position in Arteris in the 3rd quarter worth approximately $226,000. Geode Capital Management LLC raised its stake in Arteris by 6.6% during the 3rd quarter. Geode Capital Management LLC now owns 597,116 shares of the company's stock valued at $4,610,000 after purchasing an additional 36,908 shares during the period. Finally, US Bancorp DE purchased a new stake in shares of Arteris in the third quarter valued at $34,000. 64.36% of the stock is owned by institutional investors.
Analyst Ratings Changes
Separately, Rosenblatt Securities reissued a "buy" rating and issued a $15.00 price objective on shares of Arteris in a research report on Wednesday, November 6th.
Read Our Latest Report on AIP
Arteris Company Profile
(
Get Free Report)
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Arteris, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.
While Arteris currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
